Sculptor Capital LP reduced its stake in shares of ANSYS, Inc. (NASDAQ:ANSS – Free Report) by 32.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 162,400 shares of the software maker’s stock after selling 79,300 shares during the quarter. ANSYS comprises about 1.0% of Sculptor Capital LP’s investment portfolio, making the stock its 29th biggest position. Sculptor Capital LP owned 0.19% of ANSYS worth $52,212,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors also recently added to or reduced their stakes in the company. Quest Partners LLC purchased a new stake in shares of ANSYS in the fourth quarter valued at approximately $29,000. DT Investment Partners LLC boosted its holdings in shares of ANSYS by 888.9% in the second quarter. DT Investment Partners LLC now owns 89 shares of the software maker’s stock valued at $29,000 after purchasing an additional 80 shares during the period. Redwood Wealth Management Group LLC purchased a new stake in shares of ANSYS in the second quarter valued at approximately $32,000. Rothschild Investment LLC bought a new position in ANSYS in the second quarter worth approximately $38,000. Finally, Core Wealth Advisors Inc. bought a new position in ANSYS in the fourth quarter worth approximately $40,000. 92.39% of the stock is owned by institutional investors.
ANSYS Stock Performance
Shares of ANSS opened at $324.84 on Friday. The stock has a 50-day moving average of $315.64 and a two-hundred day moving average of $324.77. ANSYS, Inc. has a one year low of $258.01 and a one year high of $364.31. The company has a debt-to-equity ratio of 0.13, a quick ratio of 2.95 and a current ratio of 2.95. The stock has a market cap of $28.39 billion, a P/E ratio of 65.23, a P/E/G ratio of 6.89 and a beta of 1.12.
Insider Activity at ANSYS
In related news, Director Glenda Dorchak sold 159 shares of the company’s stock in a transaction that occurred on Monday, July 8th. The stock was sold at an average price of $330.81, for a total value of $52,598.79. Following the transaction, the director now directly owns 3,782 shares in the company, valued at $1,251,123.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.46% of the stock is currently owned by insiders.
Analysts Set New Price Targets
A number of equities analysts recently commented on the stock. KeyCorp assumed coverage on shares of ANSYS in a research note on Thursday, June 27th. They issued a “sector weight” rating for the company. StockNews.com began coverage on shares of ANSYS in a research note on Sunday, September 22nd. They issued a “hold” rating for the company. Finally, Rosenblatt Securities reduced their price target on ANSYS from $345.00 to $335.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 6th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $318.33.
Read Our Latest Report on ANSYS
ANSYS Company Profile
ANSYS, Inc develops and markets engineering simulation software and services for engineers, designers, researchers, and students in the United States, Japan, Germany, China, Hong Kong, South Korea, rest of Europe, the Middle East, Africa, and internationally. It offers structural analysis product suite that provides simulation tools for product design and optimization; the Ansys Mechanical product, an element analysis software; LS-DYNA solver for multiphysics simulation; and power analysis and optimization software suite.
Featured Stories
- Five stocks we like better than ANSYS
- What is the S&P 500 and How It is Distinct from Other Indexes
- What Intuitive Machines’ Big NASA Contract Means for Investors
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- REITs on the Rise After Rate Cuts: Where to Invest Now
- Using the MarketBeat Dividend Yield Calculator
- Is Viking Therapeutics Ready For Another Surge?
Receive News & Ratings for ANSYS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANSYS and related companies with MarketBeat.com's FREE daily email newsletter.